Literature DB >> 8013069

Effects of III-IV linker mutations on human heart Na+ channel inactivation gating.

H A Hartmann1, A A Tiedeman, S F Chen, A M Brown, G E Kirsch.   

Abstract

Na+ channel inactivation, a critical determinant of refractoriness, differs in cardiomyocytes and neurons. In rat brain type IIa (rB2a) Na+ channels, a critical residue in the cytoplasmic linker between domains III and IV regulates fast inactivation such that a Phe-->Gln substitution (F1489Q) inhibits inactivation by at least 85%. Since this residue is conserved in voltage-gated Na+ channels, we tested whether F1485Q, the analogous mutation in human heart (hH1a) Na+ channels, has a similar functional effect. We found that fast inactivation in wild-type (WT) channels expressed in Xenopus oocytes was complete within 15 milliseconds at a test potential of 0 mV, and its time course was biexponential with time constants of 0.4 and 2 milliseconds. But in contrast to rB2a, the FQ mutation inhibited inactivation by < 50% and increased mean single-channel open time by only twofold. Residual fast inactivation was monoexponential, with a time constant similar to that of the slower phase of normal inactivation (2 milliseconds). In the mutant channels, unlike WT, null tracings were absent at holding potentials in the range of -140 to -120 mV, and the voltage range of steady-state inactivation coincided exactly with that of activation, suggesting that residual inactivation was tightly coupled to the open state. As in rB2a, simultaneous mutations of I1484Q and M1486Q, in addition to mutation F1485Q, completely inhibited fast inactivation. Our results show that in heart Na+ channels, the IFM cluster controls the stability of both open- and closed-channel inactivation in a manner qualitatively similar to that in the brain. Structural differences in the putative inactivation receptor may explain the distinct gating patterns in channel subtypes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013069     DOI: 10.1161/01.res.75.1.114

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  41 in total

1.  Effects of channel cytoplasmic regions on the activation mechanisms of cardiac versus skeletal muscle Na(+) channels.

Authors:  E S Bennett
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  The [beta]2a subunit is a molecular groom for the Ca2+ channel inactivation gate.

Authors:  S Restituito; T Cens; C Barrere; S Geib; S Galas; M De Waard; P Charnet
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

3.  A single residue differentiates between human cardiac and skeletal muscle Na+ channel slow inactivation.

Authors:  Y Y Vilin; E Fujimoto; P C Ruben
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

4.  Role of the C-terminal domain in inactivation of brain and cardiac sodium channels.

Authors:  M Mantegazza; F H Yu; W A Catterall; T Scheuer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

5.  The outermost lysine in the S4 of domain III contributes little to the gating charge in sodium channels.

Authors:  Michael F Sheets; Dorothy A Hanck
Journal:  Biophys J       Date:  2002-06       Impact factor: 4.033

6.  Lidocaine partially depolarizes the S4 segment in domain IV of the sodium channel.

Authors:  Michael F Sheets; Tiehua Chen; Dorothy A Hanck
Journal:  Pflugers Arch       Date:  2010-10-28       Impact factor: 3.657

7.  Charge immobilization of the voltage sensor in domain IV is independent of sodium current inactivation.

Authors:  Michael F Sheets; Dorothy A Hanck
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

Review 8.  Computational biology in the study of cardiac ion channels and cell electrophysiology.

Authors:  Yoram Rudy; Jonathan R Silva
Journal:  Q Rev Biophys       Date:  2006-07-19       Impact factor: 5.318

9.  Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.

Authors:  Megan M McNulty; Gabrielle B Edgerton; Ravi D Shah; Dorothy A Hanck; Harry A Fozzard; Gregory M Lipkind
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

10.  Using lidocaine and benzocaine to link sodium channel molecular conformations to state-dependent antiarrhythmic drug affinity.

Authors:  Dorothy A Hanck; Elena Nikitina; Megan M McNulty; Harry A Fozzard; Gregory M Lipkind; Michael F Sheets
Journal:  Circ Res       Date:  2009-08-06       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.